Authors: MELLSTROM D GAUSENILSSON I MATTSSON LA ODEN A OLSSON JO STENSTROM M UVEBRANT M

Citation: D. Mellstrom et al., RISK-FACTORS OF OSTEOPOROSIS IN A SCREENING STUDY OF 10,364 WOMEN AGED 49-69 YEARS, Journal of bone and mineral research, 12, 1997, pp. 521-521

Authors: GAUSENILSSON I JOHNELL O ODEN A MELLSTROM D OLSSON JO UVEBRANT M MATTSON LA

Citation: I. Gausenilsson et al., DECLINE OF BONE MASS IN 10,364 WOMEN AGED 49-69 YEARS - AGE OR MENOPAUSAL EFFECT, Journal of bone and mineral research, 12, 1997, pp. 610-610

Authors: STADBERG E MATTSSON LA UVEBRANT M

Citation: E. Stadberg et al., LOW-DOSES OF 17-BETA-ESTRADIOL AND NORETHISTERONE ACETATE AS CONTINUOUS COMBINED REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN - LIPID METABOLIC EFFECTS, Menopause, 3(2), 1996, pp. 90-96

Authors: STADBERG E MATTSSON LA UVEBRANT M

Citation: E. Stadberg et al., 17-BETA-ESTRADIOL AND NORETHISTERONE ACETATE IN LOW-DOSES AS CONTINUOUS COMBINED HORMONE REPLACEMENT THERAPY, Maturitas, 23(1), 1996, pp. 31-39

Authors: MATTSSON LA SAMSIOE G VONSCHOULTZ B UVEBRANT M WIKLUND I

Citation: La. Mattsson et al., TRANSDERMALLY ADMINISTERED ESTRADIOL COMBINED WITH ORAL MEDROXYPROGESTERONE ACETATE - THE EFFECTS ON LIPOPROTEIN METABOLISM IN POSTMENOPAUSAL WOMEN, British journal of obstetrics and gynaecology, 100(5), 1993, pp. 450-453